Is Wall Street High Or Low On Thermo Fisher Scientific Inc. (TMO)?


Thermo Fisher Scientific Inc. (NYSE:TMO) finished Thursday with a subtraction of -$2.95 to close at $517.34, a downside of -0.57 percent. An average of 1,020,355 shares of common stock have been traded in the last five days. There was a fall of -$22.00 in the past week, and it reached a new high 12 times over the past 12 months. The last 20 days have seen an average of 1,115,204 shares traded, while the 50-day average volume stands at 1,163,417.

TMO stock has decreased by -9.19% in the last month. The company shares reached their 1-month lowest point of $513.04 on 09/23/22. With the stock rallying to its 52-week high on 01/03/22, shares of the company touched a low of $497.83 and a high of $672.34 in 52 weeks. It has reached a new high 1 time so far this year and lost -22.02% or -$147.96 in price. In spite of this, the price is down -23.05% from the 52-week high.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Insider Transactions

39 days have passed since Thermo Fisher Scientific Inc. (TMO) last reported insider trading activity. Williamson Stephen, who is Sr. VP and CFO, most recently acquired $12,300 shares at $603.48 per share on Aug 15. In this transaction, the insider spent $7,422,789. Sr. VP and CFO, Williamson Stephen, disposed of 15,000 shares at a price of $601.32 on Aug 12. The insider now owns more than $9,019,813 worth of shares. Prior to that, SVP and General Counsel Boxer Michael A went on to Sale 7,283 shares at $590.80 each on Aug 08. An amount of $4,302,796 was transacted.

Valuation Metrics

Thermo Fisher Scientific Inc. (TMO) has a trailing price-to-earnings (P/E) ratio of 27.68. The stock’s beta is 0.86. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 4.85, the price-to-book (PB) ratio at 4.82, and the price-to-cash flow ratio at 35.17.

The company has a payout ratio of 5.70%. The company’s most recent quarterly dividend payment was $0.30 a share, without any change from last year. Its latest increase dividend $0.04 reported on Wednesday February 23 2022.

Financial Health

The quick ratio of Thermo Fisher Scientific Inc. for the three months ended June 29 was 1.10, and the current ratio was 1.60, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.69 and a total debt to equity ratio of 0.72 for the quarter ending June 29. Its gross profit as reported stood at $19.64 billion compared to revenue of $39.21 billion.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Thermo Fisher Scientific Inc.’s return on assets was 8.50%.

Earnings Surprise

For the three-month period that ended June 29, Thermo Fisher Scientific Inc. had $29.25 billion in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $1.66 billion in the quarter, while revenues of $2.21 billion were shrunk -9.86%. The analyst consensus anticipated Thermo Fisher Scientific Inc.’s latest quarter earnings to come in at $4.99 per share, but it turned out to be $5.51, a 10.40% surprise. For the quarter, EBITDA amounted to $2.84 billion. Shareholders own equity worth $391.79 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Thermo Fisher Scientific Inc. (TMO) price momentum. RSI 9-day as of the close on 22 September was 24.24%, suggesting the stock is oversold, with historical volatility in this time frame at 11.36%.

As of today, TMO’s price is $527.42 -4.06% or -$22.00 from its 5-day moving average. TMO is currently trading -11.30% lower than its 20-day SMA and -4.81% lower than its 100-day SMA. However, the stock’s current price level is -1.21% below the SMA50 and -17.40% below the SMA200.

The stochastic %K and %D were 4.92% and 6.05%, respectively, and the average true range (ATR) was 12.16. With the 14-day stochastic at 9.31% and the average true range at 12.36, the RSI (14) stands at 30.96%. The stock has reached -16.95 on the 9-day MACD Oscillator while the 14-day reading was at -25.41.

Analyst Ratings

Credit Suisse launched coverage on Thermo Fisher Scientific Inc. (NYSE: TMO) in its analyst report released on August 25, 2022. The firm assigned the stock a Neutral rating. The consensus rating for Thermo Fisher Scientific Inc. (TMO) among analysts is Overweight. According to current brokerage recommendations, 1 brokerage firm advise that investors sell TMO, while 5 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 3 analysts, while 15 others rate it as a “buy”.

What is TMO’s price target for the next 12 months?

Analysts predict a range of price targets between $525.00 and $715.00, with a median target of $667.50. Taking a look at these predictions, the average price target given by analysts for Thermo Fisher Scientific Inc. (TMO) stock is $660.15.


Please enter your comment!
Please enter your name here